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In vitro antibacterial activityAbstract Urinary tract infection (UTI) has become a more grievous problem today, due to mul-
tidrug resistance of infecting Gram-positive (GP) and Gram-negative (GN) bacteria, sometimes
even with multiple infections. This study examines effectivity of 9 tropical ﬂowering plants
(Anogeissus acuminata, Azadirachta indica, Bauhinia variegata, Boerhaavia diffusa, Punica grana-
tum, Soymida febrifuga, Terminalia chebula, Tinospora cordifolia and Tribulus terrestris) for possible
use as source of antimicrobials for multidrug resistant (MDR) bacteria, along with main-stream
antibiotics. Pathogenic bacteria were isolated from urine samples of patients attending and admit-
ted in the hospital. Antibiograms of 11 isolated bacteria (GPs, Enterococcus faecalis and
Staphylococcus aureus; and GNs, Acinetobacter baumannii, Citrobacter freundii, Enterobacter aero-
genes, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris
and Pseudomonas aeruginosa) were ascertained by the disc-diffusion method, and antibacterial
effectivity of plant extracts was monitored by the agar-well diffusion method. Isolated bacteria were
ﬂoridly MDR to most antibiotics of the day. Methanol extracts of 9 plants were used, and extracts
of 3 plants, A. acuminata, P. granatum and S. febrifuga at least caused 25–29 mm as the maximum
size of zone of inhibition on bacterial lawns. Minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC) values of methanol extracts of 9 plants were recorded. The
methanol extract of A. acuminata had 0.29 mg/ml as the lowest MIC value and 0.67 mg/ml as the
lowest MBC value, against MDR S. aureus, signifying effectivity; but, it had the highest MIC value
Antibacterial activity of medicinal plants against MDR bacteria 85of 3.41 mg/ml. and the highest MBC value of 4.27 mg/ml for most other MDR bacteria including
E. coli. Qualitative phytochemical analysis was done for these 9 plants and information on leading
phytochemicals was presented retrieved from PubChem database. Thus, three effective-most plants
in controlling MDR-UTI bacteria in vitro were A. acuminata, P. granatum and S. febrifuga, which
can be promoted as complementary medicine.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Urinary tract infection (UTI) was mostly caused by Gram neg-
ative (GN) bacteria, predominately by Escherichia coli and by
mixed infections of (Gram positive, GP) Staphylococcus
aureus, Enterococcus faecalis, including other GNs, Klebsiella
pneumoniae, Pseudomonas aeruginosa, Acinetobacter bauman-
nii, Enterobacter aerogenes, Proteus mirabilis, Citrobacter
freundii, Proteus vulgaris and Klebsiella oxytoca in the decreas-
ing order of prevalence, when monitored in the Institute of
Medical Sciences and Sum Hospital, for example (Mishra
et al., 2013). The infecting bacteria normally constitute the fae-
cal ﬂora, and the UTI episode is initiated, when the urine ﬂow
in an individual is obstructed by one of several reasons such as,
strictures, calculi, tumours, prostatic hypertrophy, vesi-
courethral reﬂux, diabetes, anal disease, pregnancy, catheteri-
zation, some surgical procedure at the urinogenital region
and cystoscopy (Saint et al., 2002). The infecting bacteria
invade urethra and bladder with a compromised body defense
mechanism and decreased urine ﬂow. In these conditions, the
bacteria ascend via urethra move to the bladder mucosa, colo-
nize, multiply and cause inﬂammation; this causes intolerable
pain, burning, frequency and urgency of urination, nocturia,
foul smelling, cloudy urine and haematuria. Indeed, at the
onset of the problem, the patient reports to the physician
and an empiric therapy is started before the culture report of
the urine sample is obtained.
If any infection in a patient is not controlled, infecting
microbes get resistance to the applied antibiotics intrinsically
and a drug resistant cell survives and predominates with con-
comitant bacterial genetic exchanges mechanisms (McMurry
and Levy, 2011). In short, there are several factors of antibiotic
resistance in pathogenic bacteria and this situation has become
a clinical consternation. A physician often prescribes some
higher generation antibiotics in empiric therapy to avoid the
debacle from treatment failure arising from the possible pres-
ence of MDR bacteria. And the UTI being a graver problem
than imagined because of frequent attacks in females mainly,
some complementary/adjuvant/synergistic therapeutic strategy
is warranted.
Furthermore, information from ethnobotany/traditional
medicine has been seen useful for several health complications
other than infectious diseases. Nine ﬂowering plants
(Anogeissus acuminata, Azadirachta indica, Bauhinia variegata,
Boerhaavia diffusa, Punica granatum, Soymida febrifuga,
Terminalia chebula, Tinospora cordifolia and Tribulus
terrestris) (Fig. 1) were used. These plants are in use tradition-
ally by local ethnic tribes against infectious diseases; and these
were examined in a systematic screening with UTI causing bac-
teria for use as source of non-microbial antimicrobials, so that
these could serve as complementary medicine, along withmainstream drugs, the antibiotics, as it takes 3–4 days of time
of arrival of the culture report of the urine during which per-
iod, infecting bacteria cause further problems. UTI episodes
need to be controlled with an iron hand. And to avoid the
use of any antibiotic of higher generation during empiric ther-
apy, complementary or synergistic therapy using phyto-drugs
with any ongoing antibiotic could be prudently used against
UTI.
In continuation to previous work on scientiﬁc veriﬁcation of
ethnomedicinal information of a group of plants from
Kalahandi (Odisha) forest (Mishra and Padhy, 2013; Rath
and Padhy, 2014), the cited 9 plants were selected. These plants
were too recorded in Indian pharmacopeia (Anonymous, 2014),
as plants frequently used against general infectious diseases:
A. acuminata is in use for UTI and skin diseases; whole plant
of A. indica is used as an antiseptic; B. variegata is used against
diarrhoea and throat infections; B. diffusa is used for UTI and
dysentery; P. granatum is used for treating diarrhoea, dysentery
and throat problems; S. febrifuga is used against diarrhoea,
dysentery and UTI; T. chebula is used for diarrhoea and dysen-
tery;T. cordifolia has anti-tubercular activity; andT. terrestris is
used against UTI. Several other plants, Terminalia alata,
Lantana camara, Combretum albidum andWoodfordia fruticosa
had comparable antibacterial activities, which had been used for
further pharmacognostical studies (Rath andPadhy, 2012;Rath
and Padhy, 2013; Dubey et al., 2014; Sahu et al., 2014), but these
9 cited plants were not used for the isolation of individual com-
pounds against any bacteria. Detailed antibacterial work with
pathogenic bacteria isolated from clinical samples of patients
in the hospital, with 9 plants is described.2. Materials and methods
2.1. Collection of plants and extract preparation
Plants reported were collected from the Kandha tribe at hills of
Eastern range of mountains of India, in the district Kalahandi,
Odisha in January 2014. About 50 respondents of 25 hamlets
were interviewed in a forest patch and the recorded informa-
tion was documented (Table 1, Fig. 1), with the snowball
method of survey and sampling. Methanol extracts of dried
leaf samples dissolved in 10% v/v dimethyl sulfoxide
(DMSO) were used, as detailed (Mishra and Padhy, 2013).
2.2. Isolation, identiﬁcation of bacterial strains and antibiotic
sensitivity test
Two GPs, E. faecalis and S. aureus including 9 GNs, A. bau-
mannii, C. freundii, E. aerogenes, E. coli, K. oxytoca,
Figure 1 Photographs of plants: a, Anogeissus acuminata; b, Azadirachta indica; c, Bauhinia variegata; d, Boerhaavia diffusa; e, Punica
granatum; f, Soymida febrifuga; g, Terminalia chebula; h, Tinospora cordifolia; i, Tribulus terrestris.
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used in this study. All these bacteria were directly isolated from
urine samples of UTI patients attending and other patients
admitted in the hospital (see, Mishra et al., 2013).
Identiﬁcation of pathogenic bacterial strains was done depend-
ing upon gross colony morphology and biochemical tests of
isolated pure bacterial cultures, along with Microbial Type
Culture Collection (MTCC), Chandigarh, reference strains
(Mishra and Padhy, 2013). All bacterial strains were subjected
to antibiotic sensitivity tests by the Kirby-Bauer’s disc diffu-
sion method, using a 4 mm thick Mueller–Hinton (MH) agar
(HiMedia, Mumbai) medium, following the standard antibi-
otic susceptibility test chart of Clinical Laboratory Standard
Institute guidelines (CLSI, 2011). The use of urine samples
does warrant ethical approval of the institute.
2.3. Antibacterial test of plant extracts
One strain from each bacterial species having resistance to a
maximum number of presently used antibiotics was further
used for monitoring antibacterial potentiality of methanol leaf
extracts with gentamicin 30 lg/ml as the reference standard, by
the agar-well diffusion method, as previously detailed (Mishra
and Padhy, 2013; Rath and Padhy, 2014). Antibacterial activ-
ities were evaluated as before (Mishra and Padhy, 2013) and
results of the third repetition are presented.2.4. Determinations of MIC and MBC of plant extracts
Original stock solutions of leaf extracts were prepared with
methanol, at 44.44 mg plant extract/ml 10% DMSO solution,
with distilled water. Each stock solution was diluted to obtain
ﬁnal concentrations of 0.29, 0.67, 1.51, 3.41, 4.27, 9.63, 21.67
and 44.44 mg/ml with the DMSO solution. Minimum inhibi-
tory concentration (MIC) and minimum bactericidal concen-
tration (MBC) of the methanol leaf extracts were determined
in a well on a 96-welled (12 · 8) micro-titre plate (Fig. 2), as
described elsewhere (Mishra and Padhy, 2013; Rath and
Padhy, 2014).2.5. Qualitative phytochemical analyses
The following tests were performed for selected 9 medicinal
plants for the presence of alkaloids, carbohydrates, saponins,
ﬂavonoids, steroids/terpenes, tannins, resins, glycosides, and
anthraquinones, as detailed previously (Dubey and Padhy,
2013).
2.6. Statistical analysis
Kruskal–Wallis H test for data of zone of inhibition as
antibacterial activities in agar-cup method of 3 comparable
Table 1 Ethnomedicinal report of 9 medicinal plants used against urinary tract infection causing bacteria.
Sl.
No
Plant name Family English name;
Local name
Parts
used
Ethnomedicinal uses
1 Anogeissus acuminata
(Roxb.ex.DC) wall.ex Guill.
and perr.)
Combretaceae Button tree;
Phasi
Leaf/
Bark
Its leaf has wound healing activity; used for inﬂammation,
urinary tract infection (UTI) and skin diseases. Its bark is used to
treat diabetes
2 Azadirachta indica L. Adelb Meliaceae Neem;
Neemba
Leaf It is used as an antiseptic and for antiviral action (chicken pox).
It is used for the treatment of acne
3 Bauhinia variegata L. Fabaceae Mountain
ebony;
Kanchan
Leaf/
Root
Its leaf is used for burning sensation during urination. The roots
are used for digestive problems, diarrhoea and throat infections
4 Boerhaavia diﬀusa L. nom.
cons.
Nyctaginaceae Hog weed;
Atika podi
Leaf It is used to improve eyesight, to treat UTI, dysentery and
diabetes
5 Punica granatum L. Lythraceae Pomegranate;
Dalimba
Leaf/
Bark/
Fruits
It is used for diarrhoea, dysentery, intestinal parasites, kidney
problems, heart and throat problems; it is used to stop nose
bleeds and gum bleeds and as an eye drop to slow the
development of cataracts
6 Soymida febrifuga Roxb. Meliaceae Indian
redwood;
Rohini
Leaf/
Bark
It is used in the treatment of diarrhoea, dysentery, UTI, fever,
vaginal infections, rheumatism swellings
7 Terminalia chebula Retz. Combretaceae Chebulic
myrobala;
Harida
Leaf/
Fruits
Its leaves are used in skin disorders, anaemia, narcosis, piles,
fever, diarrhoea, dysentery, cough and UTI; fruits are used for
constipation and anorexia
8 Tinospora cordifolia
(Thunb.) Miers
Menispermaceae Heart-leaved
moonseed;
Guluchi
Leaf/
Bark
It has hepato-protective activity; commonly it is used for diabetes
and also to treat tuberculosis
9 Tribulus terrestris L. Zygophyllaceae Puncture vine;
Gokhura
Leaf It is used to treat kidney, bladder, UTI and sexual problems
Figure 2 Determination of minimum inhibitory concentrations
(MICs), in a 96-well microtiter plate, of 44.44 mg/ml of methanol
leaf extract of P. granatum against 8 MDR UTI causing
pathogenic bacteria (1 = S. aureus, 2 = E. faecalis, 3 =
A. baumannii, 4 = E. aerogenes, 5 = K. pneumoniae, 6 = K.
oxytoca, 7 = P. mirabilis, 8 = P. vulgaris). M =MIC at numbers
that signiﬁes the lowest concentration of leaf extract. C = control
without plant leaf extract; A = Gentamicin (30 lg/ml) as control
without any plant leaf extract.
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Package for Medical Science version 17.0 (SPSS Inc., IL,
USA).3. Results
3.1. Collection of plants
Ethnomedicinal information on 9 selected medicinal plants are
documented along with the details of modalities on crude
extracts as medicine for many ailments used by local ethnic
aborigine groups (Table 1). Most of these plants are used for
infectious diseases and were found edible as medicines by the
aborigine society.
3.2. Antibiotic sensitivity test of bacteria
The antibiotic proﬁle of each pathogenic bacterium was deter-
mined using speciﬁed antibiotic discs (Table 2). GP isolates, E.
faecalis were resistant to 17 and S. aureus were resistant to 13
of 18 antibiotics used. Among the nine GN isolates, A. bau-
mannii, E. aerogenes, and E. coli were resistant to 11, C. fre-
undii, K. pneumoniae, K. oxytoca and P. aeruginosa were
resistant to 12, P. mirabilis and P. vulgaris were resistant to
10 antibiotics of the total 14 antibiotics used. The details of
individual antibiotics resistant proﬁles of individual bacteria
are presented (Table 2). Thus, all isolated bacterial strains were
MDR.
3.3. Antibacterial test of plant extracts
Methanol extracts of medicinal plants when tested against
MDR strains of 11 bacteria, 3 plants, A. acuminata, P. grana-
tum and S. febrifuga were seen most effective, with at least
causing 25 to 29 mm diameter-sizes of zone of inhibition
Table 2 Antibiotic susceptibility results of multidrug resistant Gram-positive and Gram-negative bacteria.
Bacterium Susceptibility to prescribed antibiotics
Aminoglycosides b-lactams Cephalosporin Fluoroquinolones Glyco-
peptides
Lincosa-mide Sulfonamide Stand
alones
Ac Ge Ak Am Ox Pt Ce Cf Of Le Nx Gt Tei Va Cd Cot Ch Lz
E. faecalis* R R R R R R R R R R R R R S R R R R
S. aureus* R R R R MS R R R R R R R MS MS MS R R S
A. baumannii R R R R ND R R R R R MS S ND ND ND R R S
C. freundii R R R R ND R R R R R R MS ND ND ND R R S
E. aerogenes R R R R ND R R R R R R MS ND ND ND R MS S
E. coli R R R R ND S R R R R R R ND ND ND S R S
K. oxytoca R R R R ND R R R R R R MS ND ND ND S R R
K. pneumoniae R R R R ND R R R R R R S ND ND ND R R S
P. mirabilis R R R R ND S R R S R S MS ND ND ND R R R
P. vulgaris R R R S ND R R S S R R S ND ND ND R R R
P. aeruginosa R R R R ND R R R R R R MS ND ND ND R R S
Note: ‘*’ marked bacteria are Gram-positives and the rest are Gram-negatives. R: Resistant; S: Sensitive; MS: moderately sensitive; ND: not
done. Antibiotics (lg/disc), Ac: amikacin 30; Ak: amoxyclav 30; Am: ampicillin 10; Cd: clindamycin 2; Cf: cefpodoxime 10; Ch: chloram-
phenicol 30; Cot: co-trimoxazole 25; Ce: ceftriaxone 30; Ge: gentamicin 10; Gt: gatiﬂoxacin 5; Nx: norﬂoxacin 10; Le: levoﬂoxacin 5; Lz:
linezolid 30; Of: oﬂoxacin 5; Ox: oxacillin 1; Pt: piperacillin/tazobactam 100/10; Tei: teicoplanin 5; Va: vancomycin 30.
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registered the highest value of inhibition zone of 27 mm,
against S. aureus and the lowest value of 20 mm against P. mir-
abilis was recorded; but, inhibition zone values due to A.
acuminata were recorded for other given bacteria (mm): E. fae-
calis (24), A. baumannii (23), C. freundii (22), E. aerogenes (21),
E. coli (22), K. oxytoca (23), K. pneumoniae (24), P. vulgaris
(21) and P. aeruginosa (25). Thus, A. acuminata extract was
effectively capable of controlling all the 11 MDR bacteria.
Methanol leaf extract of A. indica had shown the highest
inhibition-zone size of 22 mm against E. aerogenes, while the
lowest value was 12 mm against P. mirabilis. Methanol leaf
extract of P. granatum had the highest value of inhibition-
zone size, 26 mm against S. aureus and the lowest value of
17 mm was against P. mirabilis; the extract was effectively cap-
able of controlling all the 11 MDR pathogens by registering
values of inhibition zones ranging from 18 to 25 mm. The
highest value of inhibition-zone size of 25 mm against S. aur-
eus and the lowest value of 17 mm against E. aerogenes had
been noted due to the methanol extract of S. febrifuga; and
20, 23, 21, 19, 22, 21, 19, 20 and 28 mm values of size of zone
of inhibition were recorded against the pathogenic bacteria,
E. faecalis, A. baumannii, C. freundii, E. coli, K. oxytoca, K.
pneumoniae, P. mirabilis, P. vulgaris and P. aeruginosa, respec-
tively. The methanol leaf extract of S. febrifuga had an effec-
tive controlling capacity over all the pathogens. Methanol
leaf extracts of the rest 6 plants had moderate control capacity
on all bacterial strains (Table 3). The total size of zone of inhi-
bition of all used plants is arranged according to the decreasing
order, A. acuminata > P. granatum> S. febrifuga >
A. indica > B. variegata > T. terrestris > T. cordifolia >
T. chebula > B. diffusa. Moreover, Kruskal–Wallis H test
for data of zone of inhibition of the 3 best plants, A. acumi-
nata, P. granatum and S. febrifuga yielded the H-value of
0.83, which was statistically not signiﬁcant; so, these 3 plants
were inferred as equally effective for antibacterial activity.3.4. MIC and MBC of plant extracts
The methanol leaf extract of A. acuminata had the lowest MIC
value, 0.29 mg/ml and the lowest MBC value 0.67 mg/ml
against S. aureus; MIC value of 0.67 mg/ml and MBC value
of 1.51 mg/ml against E. faecalis, K. pneumoniae and P. aerug-
inosa, while MIC value of 1.51 mg/ml and MBC value of
3.41 mg/ml against A. baumannii and K. oxytoca were recorded
by A. acuminata. On the other hand, the highest MIC value of
3.41 mg/ml, and the highest MBC value of 4.27 mg/ml due to
A. acuminata extract were noted for C. freundii, E. aerogenes,
E. coli, P. mirabilis and P. vulgaris. The methanol leaf extract
of P. granatum showed the lowest MIC value of 0.29 mg/ml
and the lowest MBC value of 0.67 mg/ml against S. aureus;
MIC value of 0.67 mg/ml and MBC value of 1.51 mg/ml was
noted against C. freundii, E. coli and P. aeruginosa; MIC value
of 1.51 mg/ml and MBC value of 3.41 mg/ml was recorded
against E. faecalis; MIC value of 3.41 mg/ml and MBC value
of 4.27 mg/ml were recorded against A. baumannii, E. aeroge-
nes, K. oxytoca and K. pneumoniae. The highest MIC value of
4.27 mg/ml and MBC value of 9.63 mg/ml by the extract of
P. granatum were noted against P. mirabilis and P. vulgaris.
The methanol leaf extract of S. febrifuga showed the lowest
MIC value of 0.67 mg/ml and the lowest MBC value of
1.51 mg/ml against S. aureus. MIC value of 1.51 mg/ml and
MBC value of 3.41 mg/ml were recorded against A. baumannii.
By the extract of S. febrifuga, MIC value 3.41 mg/ml and MBC
value 4.27 mg/ml were noted against E. faecalis, C. freundii, K.
oxytoca, K. pneumoniae and P. vulgaris and the highest MIC
value of 4.27 mg/ml and MBC value of 9.63 mg/ml were
recorded against E. aerogenes, E. coli, P. mirabilis and P.
aeruginosa. The MIC and MBC values of leaf extracts of rest
other plants were recorded (Table 4). A lower MIC/MBC
value signiﬁes that a minimum amount of plant extract is used,
whereas, a higher value signiﬁes the use of comparatively more
amount of plant extract for the control of any bacterium.
Table 3 Antibacterial activity as size of zone of inhibition due to 9 selected medicinal plants against bacteria with gentamicin 30 lg/ml
as the positive control.
Bacteria Size of zone of inhibition by plants (Nos. 1 to 9) methanol extracts (mm)
A. acuminata A. indica B. variegata B. diﬀusa P. granatum S. febrifuga T. chebula T. cordifolia T. terrestris Ge 30 lg/ml
E. faecalis 24 18 17 15 23 20 18 17 19 25
S. aureus 27 20 21 17 26 25 23 19 21 28
A. baumannii 23 17 14 13 22 23 15 – 15 20
C. freundii 22 21 13 12 24 21 – 13 13 21
E. aerogenes 21 22 15 14 20 17 – 14 – 23
E. coli 22 19 19 10 25 19 14 16 17 26
K. oxytoca 23 15 15 13 21 22 15 15 16 22
K. pneumoniae 24 17 17 15 18 21 13 13 15 20
P. mirabilis 20 12 12 – 17 19 11 11 18 22
P. vulgaris 21 13 14 – 19 20 – – 17 23
P. aeruginosa 25 15 20 15 24 18 16 18 20 26
Total zone size 252 189 177 124 239 225 125 136 171
Note: Numbers 1 to 9 are serial numbers of plants given in Table 1; Ge, gentamicin. Values are measurements of zone of inhibition due to
methanol-extracts. ‘‘–’’ sign denotes no activity. Kruskal–Wallis H test for data of zone of inhibition of 3 plants, A. acuminata, P. granatum and
S. febrifuga yielded the H-value of 0.83, which was statistically not signiﬁcant; so, these 3 plants were equally effective for antimicrobial activity.
The rest other 6 plants were clearly lesser in antimicrobial activity in comparison to cited 3 plants. It was conﬁrmed that 10% DMSO had no
inhibitory effect on any bacterium.
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Qualitative phytochemical analyses were done for methanol
leaf extracts. Phytochemicals, alkaloids, ﬂavonoids, carbohy-
drates, terpenoids, steroids, tannins, resins, saponins and
anthraquinones, which could be attributed to the recorded sig-
niﬁcant antibacterial activities in most extracts (Table 5). From
PubChem database, structure and related information of one
leading antimicrobial compound of each plant was presented
(Table 6). From previous studies, the antibacterial nature of
these cited 9 compounds were ascertained (Table 6). The
Molsoft tool (http://molsoft.com/mprop/) was used to ﬁnd
out the drug likeness scores of each compound, according to
their structure canonical ‘simpliﬁed molecular-input line-entry
system’ (SMILES). Thus theoretically, based on the available
data on drug likeness scores, phytochemicals could be arranged
in the decreasing order of drug-likeness scores mentioned
against: quercetin (0.93) > berberin (0.91) > luteolin-7-O-
glugoside (0.86) > kaempferol (0.77) > ursolic acid (0.65) >
argungenin (0.61) and mahmoodin (0.61) > conocarpan
(0.13) and dihydrodedrodehydrodiconiferylalcohol (0.13) >
anolignan B (0.78). It could be inferred here that S. febrifuga
among the 3 best plants is the most leading plant with luteolin-
7-O-glugoside, which has a good score of drug-likeness
(Table 6).4. Discussion
All of these 9 plants were used by an ethnic tribe, the Kandha
tribe of Kalahandi district, since time immemorial for primary
healthcare needs speciﬁcally for infectious diseases. It was seen
that, 11 bacteria isolated from urine samples were resistant to
the following: aminoglycosides, b-lactams (amoxyclav and
ampicillin), two cephalosporins (ceftriaxone and cefpodoxime)
as well as, chloramphenicol, signifying most bacterial strains as
resistant to most antibiotics. Additionally, plants, A. acumi-
nata, A. indica, B. variegata, P. granatum and S. febrifugahad control capacity on all the 11 strains of MDR bacteria.
Moreover, among these 3 best plants in the control of MDR
bacteria in vitro were A. acuminata, P. granatum and S. febri-
fuga. P. granatum has stigmasterol, a sterol with the drug-
likeness score, 0.73 while, S. febrifuga has luteolin-7-O-
glucoside, a ﬂavonoid with the drug-likeness score, 0.86.
Further work on antibacterial bioactive compounds of
A. acuminata is in progress, as it had signiﬁcant microbial
activity. However, the plant, T. terrestris has the famous
antimicrobial agent, quercetin, which has an effective drug
likeness score of 0.93; but this plant did not have the best
antibacterial activity, in this study or with these bacteria.
Antibiotic sensitive pathogens have a limited capacity of
virulence as the employed antibiotic controls them in vivo. At
a particular density, the host defense system too helps control
pathogens, when the later are in a limiting number. As known,
for the internal protection, antibiotic producing organisms
harbour antibiotic resistant genes in plasmids and chromo-
somes, as well as the transfer mechanisms remain active
(Mamelli et al., 2009). Therefore, such genes and/or trans-
poson are taken up, horizontally by the susceptible group of
bacteria, through bacterial transformation and/or conjugation
(Pages et al., 2008; Warnes et al., 2012).
Moreover, bacteria having simple genomes undergo intrin-
sic (mutations) or acquired genetic (conjugations and transfor-
mation) changes in the presence of an antibiotic, as a stress
factor (Groisman and Ochman, 1996). As a result, accrual
antibiotic resistance mechanisms are the clinical determinants
of the pathogenesis. It had been known that in areas, where a
particular group of antibiotics are used bacteria resistance to
same antibiotics were in higher numbers (Shrestha et al.,
2002). Indeed, the horizontal transfer of genetic materials from
one organism to another appears faster than mutational
changes, a phenomenon popularly called as ‘evolution of quan-
tum leaps’ (Groisman and Ochman, 1996). Progressively, the
use of more antibiotics even of higher generations for the con-
trol of infectious diseases have led to multiple resistances, i.e.,
too many antibiotics are ineffective to progressively increasing
Table 4 MIC and MBC values of selected 9 medicinal plants and of gentamicin as the positive control against bacteria.
Bacterium MIC and MBC values by methanol extracts of 9 plants (mg/ml) Gentamicin lg/ml
1 2 3 4 5 6 7 9
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC IC MBC MIC MBC MIC MBC
E. faecalis 0.67 1.51 3.41 4.27 4.27 9.63 9.63 21.67 1.51 3.41 3.41 4.27 4.27 9.63 7 9.63 4.27 9.63 0.93 1.87
S. aureus 0.29 0.67 3.41 4.27 3.41 4.27 4.27 9.63 0.29 0.67 0.67 1.51 1.51 3.41 7 9.63 3.41 4.27 0.46 0.93
A. baumannii 1.51 3.41 4.27 9.63 9.63 21.67 9.63 21.67 3.41 4.27 1.51 3.41 9.63 21.67 – 9.63 21.67 3.75 7.50
C. freundii 3.41 4.27 3.41 4.27 9.63 21.67 9.63 21.67 0.67 1.51 3.41 4.27 – – 3 21.67 9.63 21.67 1.87 3.75
E. aerogenes 3.41 4.27 3.41 4.27 9.63 21.67 9.63 21.67 3.41 4.27 4.27 9.63 – – 3 21.67 – – 0.93 1.87
E. coli 3.41 4.27 4.27 9.63 4.27 9.63 – – 0.67 1.51 4.27 9.63 9.63 21.67 7 9.63 4.27 9.63 1.87 3.75
K. oxytoca 1.51 3.41 9.63 21.67 9.63 21.67 9.63 21.67 3.41 4.27 3.41 4.27 9.63 21.67 3 21.67 4.27 9.63 0.93 1.87
K. pneumoniae 0.67 1.51 4.27 9.63 4.27 9.63 9.63 21.67 3.41 4.27 3.41 4.27 9.63 21.67 3 21.67 9.63 21.67 1.87 3.75
P. mirabilis 3.41 4.27 9.63 21.67 9.63 21.67 – – 4.27 9.63 4.27 9.63 9.63 21.67 3 21.67 4.27 9.63 3.75 7.50
P. vulgaris 3.41 4.27 9.63 21.67 9.63 21.67 – – 4.27 9.63 3.41 4.27 – – – 4.27 9.63 1.87 3.75
P. aeruginosa 0.67 1.51 9.63 21.67 3.41 4.27 9.63 21.67 0.67 1.51 4.27 9.63 9.63 21.67 7 9.63 3.41 4.27 0.46 0.93
Note: Numbers 1 to 9 are serial numbers of plants given in Table 1. Values are measurements of MIC and MBC due to methanol extracts –’’ sign denotes no activity; Gentamicin was used as
dilutions from 30 lg/ml.
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Table 5 Qualitative phytochemical analyses of methanol extracts of 9 medicinal plants.
Sl.No. Plants Alkaloids Resins Glycosides Terpenoids Carbohydrates Saponins Tannins Flavonoids Steroids Anthraquinones
1 A. acuminata +  + + + + + + + +
2 A. indica  + + + + +   + 
3 B. variegata + + +  + + +  + +
4 B. diﬀusa +      + + + +
5 P. granatum +  + +  + + + + +
6 S. febrifuga + + + + +  + + + +
7 T. chebula + + + + +  + +  +
8 T. cordifolia +  +  + +   + 
9 T. terrestris    +     + 
Note: ‘‘+’’ sign denotes presence, and ‘‘ ‘‘sign denotes absence of the compound in a plant.
Antibacterial activity of medicinal plants against MDR bacteria 91resistant strains of pathogens, as if growth and momentum
gained by a descending snow-ball, during the passage of time
by mutation and acquisition of genes from related/unrelated
bacteria, ending in shockingly repellant multidrug bacterial
resistance. Older antibiotics slowly become moribund, even
the resistant mechanism against those are found in certain bac-
teria for which, those antibiotics were never applied. Drug
resistant bacteria gain the capability of surviving and multiply-
ing under antibiotic-stress conditions, conﬁrming the biological
rule, ‘any limiting condition for the majority would be an excel-
lent opportunity for the minority’. In the presence of a drug in a
body in vivo, the progeny of a drug sensitive strain is eliminated
and the resistant strain survives, multiplies as if, developing
from a doppelga¨nger, and predominates ultimately in causing
a characteristic pathogenesis. It is because a suitable emulating
agent for the control is absent, and if plant-based antimicrobial
would be present in parallel along with the employed antibiotic,
there would be the coveted blithesome result, since no bac-
terium how much genetically well-equipped be it may as in a
cohort of MDR bacteria, can never over-ride complexities of
phytochemicals for survival. This fact is repeatedly seen
in vitro with several plant extracts (Dubey and Padhy, 2013;
Mishra and Padhy, 2013; Rath and Padhy, 2013; Sahu et al.,
2015). Thus, those in a coalesced manner, as in a crude extract,
have a combined controlling effect.
It has been demonstrated with Salmonella enterica serotype
typhimurium (Alekshun and Levy, 1999). Moreover, MDR
Neisseria gonorrheae had been known to acquire ‘MTR and
SAP A MDR’ systems of genes, from S. enterica serotype
typhimurium (Hagman and Shaferm, 1995). Discovery and
development of antibiotics in the last century have not only
saved countless human lives, but have provided assurances in
clinical management all over. But, concomitant development
of antibiotic-resistance mainly in bacteria has dismayed both
preventive and therapeutic potencies of antibiotics today. In
the odyssey of drug development, antibiotics are introduced
continually and a few of them are modiﬁed suiting to the need
to overcome bacterial resistance. Eventually, today there are a
large number of antibiotics in use. The demand for newer
antibiotics for MDR bacteria in colossal scale has arisen,
which has become difﬁcult to meet, as these small molecules
are extremely complex in functionality linked to chemical
structure. Secondly, an antibiotic ensconced for a typical set
of infections cannot ordinarily be abandoned as an obsolete
drug, due to reports of dogmatic/realistic resistance in ageographical zone; rather, along with the same antibiotic the
introduction of complementary or adjuvant drug could be
aimed, when considered with contemplation the problem of
morbidity/mortality from infections due to MDR bacteria
(Davies and Davies, 2010).
Applied antibiotics, being of microbial origin, are readily
won over by pathogenic microbes in vivo. The cell producing
an antibiotic has the characters of the self-protective mecha-
nism as characters/genes, which direct the modes of resistance
such as, alteration in the cell membrane by efﬂux mechanism
or production of external enzymes like, b-Lactamases are
intrinsically transmitted to similar bacteria, as discussed
(Rout et al., 2014). In short, suitable antibiotics are required
in colossal scale globally, which would give a way to the
chance of development of resistant strain(s) of pathogenic
bacteria in a Darwinian way, further. Indeed, the present
methodology of methanol-extraction of phytochemicals is a
unique approach, as this solvent helps extraction of most polar
to non-polar phytocompounds (Rezaie et al., 2015). The
b-Lactam group of antibiotics consisting of penicillins, cepha-
losporins, monobactams, glycopeptides and penems target the
peptidoglycan biosynthesis of bacteria. Tetracyclines,
aminoglycosides, macrolides, lincosamides, streptogramins,
oxazolidinone (linezolid) and phenicols cause a thwart to the
translation process in the parasitic cell; quinolones inhibit
the DNA replication. Pyrimidines and sulphonamides alter
carbon metabolism during inhibition of parasitic growth;
and the most recent ones such as, daptomycin and colistin
inhibit cell membrane functions (see, Davies and Davies,
2010). However, the ﬁrst effective antimicrobials were the
sulphonamides, which have been amply lent themselves for
further uses in the drug development process as antibacterials
in the last several decades. Thus, the concept of complemen-
tary use of phytocompounds along with main stream drugs,
the antibiotics has immersed when the myriad mechanisms of
drug resistance is considered in the face of success of phyto-
compounds as non-microbial antimicrobials (Sahu et al., 2015).
Our school has screened out about 250 plants in the last
4 years (Rath and Padhy, 2012; Rath et al., 2012; Dubey and
Padhy, 2012; Mishra and Padhy, 2013; Rath and Padhy,
2014; Sahu et al., 2015), using mainly ethanol and water as
extracting solvents. Among them for 47 plants methanol was
used as the solvent (Mishra and Padhy, 2013; Rath and
Padhy, 2014). A comparative account of MIC values of the
best plants among 47 against MDR strains of 8 gruesome
Table 6 Leading antimicrobial phytochemicals structure, information with properties.
Plant name Leading antimicrobial phytochemical structure Information and properties
of leading phytochemical
Drug-
likeness
score
References
A. acuminata
Anolignan B (oc)
Molecular weight: 266.33432 [g/mol]
Molecular formula: C18H18O2
XLogP3-AA: 5.5
H-Bond donor: 2
H-Bond acceptor: 2
0.78
Rimando
et al.
(1994a,b),
Eldeen et al.
(2006)
Conocarpan (oc)
Compound ID: 6474521
Molecular Weight: 266.33432 [g/mol]
Molecular Formula: C18H18O2
XLogP3-AA: 4.4
H-Bond donor: 1
H-Bond acceptor: 2
0.13
Dihydrodehydrodiconiferylalcohol (oc)
Compound ID: 5274623
Molecular weight: 360.40096 [g/mol]
Molecular formula: C20H24O6
XLogP3-AA: 2.1
H-Bond donor: 3
H-Bond acceptor: 6
0.13
A. indica
Mahmoodin (l)
Compound ID: 126566
Molecular weight: 526.61792 [g/mol]
Molecular formula: C30H38O8
XLogP3-AA: 3.7
H-Bond donor: 1
H-Bond acceptor: 8
0.61
Siddiqui
et al. (1992)
B. variegata
Kaempferol (f)
Compound ID: 5280863
Molecular weight: 286.2363 [g/mol]
Molecular formula: C15H10O6
XLogP3: 1.9
H-Bond donor: 4
H-Bond acceptor: 6
0.77
Holler et al.
(2012)
B. diﬀusa
Ursolic acid (t)
Compound ID: 64945
Molecular weight: 456.70032 [g/mol]
Molecular formula: C30H48O3
XLogP3-AA: 7.3
H-Bond donor: 2
H-Bond acceptor: 3
0.65
Jime´nez-
Arellanes
et al. (2013)
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Table 6 (continued)
Plant name Leading antimicrobial phytochemical structure Information and properties
of leading phytochemical
Drug-
likeness
score
References
P. granatum
Stigmasterol (s)
Compound ID: 5280794
Molecular weight: 412.69082 [g/mol]
Molecular formula: C29H48O
XLogP3-AA: 8.6
H-Bond donor: 1
H-Bond acceptor: 1
0.73
Awouafack
et al. (2013)
S. febrifuga
Luteolin-7-O-glucoside (f)
Compound ID: 5291488
Molecular weight: 448.3769 [g/mol]
Molecular formula: C21H20O11
XLogP3-AA: 0.5
H-Bond donor: 7
H-Bond acceptor: 11
0.86
Khatkar
et al. (2014)
T. chebula
Arjungenin (t)
Compound ID: 12444386
Molecular weight: 504.69852 [g/mol]
Molecular formula: C30H48O6
XLogP3-AA: 4.5
H-Bond donor: 5
H-Bond acceptor: 6
0.61
Manosroi
et al. (2013)
T. cordifolia
Berberin (a)
Compound ID: 2353
Molecular weight: 336.36122 [g/mol]
Molecular formula: C20H18NO4
+
XLogP3-AA: 3.6
H-Bond donor: 0
H-Bond acceptor: 4
0.91
Choudhary
et al. (2013)
T. terrestris
Quercetin (f)
Compound ID: 5280343
Molecular weight: 302.2357 [g/mol]
Molecular formula: C15H10O7
XLogP3: 1.5
H-Bond donor: 5
H-Bond acceptor: 7
0.93
Rashed and
Butnariu
(2014)
Note: a, alkaloid; f, ﬂavonoid; l, limonoid; oc, organic compound; s, sterol; t, terpene.
Antibacterial activity of medicinal plants against MDR bacteria 93bacteria is considered, along with the present 3 best plants
(Table 7). It is discernible that methanol extracts of most
plants had MIC values as 3.41 or more, except those ofCinnamomum tamala, A. acuminata, P. granatum and S. febri-
fuga, which had comparatively lower MIC values, as 1.51 or
0.67 or 0.29 mg/ml.
Table 7 MIC values (mg/ml) of methanol leaf-extracts of plants against pathogenic bacteria.
Bacteria Ef Sa Ab Cf Ea Ec Kp Pa References
Plants
Allium sativum NE 9.63 9.63 4.27 3.41 NE 9.63 NE Rath and Padhy (2014)
Amomum aromaticum 3.41 4.27 NE NE 9.63 NE NE 4.27 Rath and Padhy (2014)
Artocarpus heterophyllus 9.63 9.63 9.63 9.63 9.63 NE 9.63 9.63 Mishra and Padhy (2013)
Cinnamomum tamala 3.41 1.51 NE NE 3.41 NE 9.63 4.27 Rath and Padhy (2014)
Dalbergia latifolia 9.63 3.41 9.63 9.63 9.63 9.63 NE 4.27 Mishra and Padhy (2013)
Gmelina arborea 9.63 3.41 9.63 9.63 NE 9.63 9.63 9.63 Mishra and Padhy (2013)
Melia azedarach 9.63 3.41 9.63 NE NE NE NE 9.63 Mishra and Padhy (2013)
Mentha spicata NE 9.63 9.63 NE 1.51 NE 3.41 4.27 Rath and Padhy (2014)
Mimusops elengi 4.27 4.27 9.63 NE 9.63 9.63 9.63 9.63 Mishra and Padhy (2013)
Myristica fragrans 3.41 NE NE 4.27 3.41 NE 9.63 9.63 Rath and Padhy (2014)
Pongamia pinnata 9.63 4.27 NE NE 9.63 NE NE 9.63 Mishra and Padhy (2013)
Pterocarpus marsupium 4.27 4.27 9.63 9.63 9.63 9.63 NE 9.63 Mishra and Padhy (2013)
Shorea robusta 9.63 4.27 9.63 9.63 NE NE 9.63 3.41 Mishra and Padhy (2013)
Anogeissus acuminata 0.67 0.29 1.51 3.41 3.41 3.41 0.67 0.67 Present work
Punica granatum 1.51 0.29 3.41 0.67 3.41 0.67 3.41 0.67 Present work
Soymida febrifuga 3.41 0.67 1.51 3.41 4.27 4.27 3.41 4.27 Present work
Note: Ef, E. faecalis; Sa, S. aureus; Ab, A. baumannii; Cf, C. freundii; Ea, E. aerogenes; Ec, E. coli; Kp, K. pneumoniae; Pa, P. aeruginosa, ND,
not done; NE, no effect.
94 M.P. Mishra et al.5. Conclusion
Antibiograms of 11 isolated pathogenic bacteria with 17
antibiotics of the day ascertained that all were amply MDR.
The work on individual 9 plants in controlling all MDR strains
of bacteria was evident, mostly with lower MIC and MBC
values. All these used plants have ethnomedicinal uses and 3
best plants could be promoted as complementary medicine.
The recorded data of 3 best plants, A. acuminata, P. granatum
and S. febrifuga, are anticipated to trigger work on the isola-
tion of pure compounds for further scientiﬁc use in the crusade
of the control of MDR bacteria. Phytocompounds, stigmas-
terol and luteolin-7-O-glucoside already isolated from the
second and the third best antibacterial plant, respectively have
signiﬁcant drug-likeness scores. Thus, the presently used three
best plants could be regarded as the most effective plants stud-
ied for further consideration for complementary medicine as
sources of non-microbial anti-microbials against most MDR
UTI causing bacteria.
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